Epidemiological analysis of methicillin-resistant Staphylococcus aureus outbreaks in a neonatal intensive care unit by genomic DNA fingerprinting using pulsed-field gel electrophoresis. 2000

A Kaneko, and H Miyazawa, and F Kirikae, and K Toyooka, and M Hashimoto, and S Yamasaki, and M Hasegawa, and C Takeuchi, and T Kuratsuji, and M Sumiya, and O Kobori, and Y Yazaki, and T Kirikae
International Medical Center of Japan, Tokyo 162-8655, Japan.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007363 Intensive Care Units, Neonatal Hospital units providing continuing surveillance and care to acutely ill newborn infants. Neonatal Intensive Care Unit,Neonatal Intensive Care Units,Newborn Intensive Care Unit,Newborn Intensive Care Units,ICU, Neonatal,Neonatal ICU,Newborn ICU,Newborn Intensive Care Units (NICU),ICU, Newborn,ICUs, Neonatal,ICUs, Newborn,Neonatal ICUs,Newborn ICUs
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004196 Disease Outbreaks Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS. Outbreaks,Infectious Disease Outbreaks,Disease Outbreak,Disease Outbreak, Infectious,Disease Outbreaks, Infectious,Infectious Disease Outbreak,Outbreak, Disease,Outbreak, Infectious Disease,Outbreaks, Disease,Outbreaks, Infectious Disease
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D015252 Deoxyribonucleases, Type II Site-Specific Enzyme systems containing a single subunit and requiring only magnesium for endonucleolytic activity. The corresponding modification methylases are separate enzymes. The systems recognize specific short DNA sequences and cleave either within, or at a short specific distance from, the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.4. DNA Restriction Enzymes, Type II,DNase, Site-Specific, Type II,Restriction Endonucleases, Type II,Type II Restriction Enzymes,DNase, Site Specific, Type II,Deoxyribonucleases, Type II, Site Specific,Deoxyribonucleases, Type II, Site-Specific,Site-Specific DNase, Type II,Type II Site Specific DNase,Type II Site Specific Deoxyribonucleases,Type II Site-Specific DNase,Type II Site-Specific Deoxyribonucleases,Deoxyribonucleases, Type II Site Specific,Site Specific DNase, Type II

Related Publications

A Kaneko, and H Miyazawa, and F Kirikae, and K Toyooka, and M Hashimoto, and S Yamasaki, and M Hasegawa, and C Takeuchi, and T Kuratsuji, and M Sumiya, and O Kobori, and Y Yazaki, and T Kirikae
April 2000, Japanese journal of infectious diseases,
A Kaneko, and H Miyazawa, and F Kirikae, and K Toyooka, and M Hashimoto, and S Yamasaki, and M Hasegawa, and C Takeuchi, and T Kuratsuji, and M Sumiya, and O Kobori, and Y Yazaki, and T Kirikae
May 1992, Nihon rinsho. Japanese journal of clinical medicine,
A Kaneko, and H Miyazawa, and F Kirikae, and K Toyooka, and M Hashimoto, and S Yamasaki, and M Hasegawa, and C Takeuchi, and T Kuratsuji, and M Sumiya, and O Kobori, and Y Yazaki, and T Kirikae
April 1991, The Journal of hospital infection,
A Kaneko, and H Miyazawa, and F Kirikae, and K Toyooka, and M Hashimoto, and S Yamasaki, and M Hasegawa, and C Takeuchi, and T Kuratsuji, and M Sumiya, and O Kobori, and Y Yazaki, and T Kirikae
December 1991, Journal of clinical microbiology,
A Kaneko, and H Miyazawa, and F Kirikae, and K Toyooka, and M Hashimoto, and S Yamasaki, and M Hasegawa, and C Takeuchi, and T Kuratsuji, and M Sumiya, and O Kobori, and Y Yazaki, and T Kirikae
July 2016, Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH,
A Kaneko, and H Miyazawa, and F Kirikae, and K Toyooka, and M Hashimoto, and S Yamasaki, and M Hasegawa, and C Takeuchi, and T Kuratsuji, and M Sumiya, and O Kobori, and Y Yazaki, and T Kirikae
October 1999, Anaesthesia and intensive care,
A Kaneko, and H Miyazawa, and F Kirikae, and K Toyooka, and M Hashimoto, and S Yamasaki, and M Hasegawa, and C Takeuchi, and T Kuratsuji, and M Sumiya, and O Kobori, and Y Yazaki, and T Kirikae
January 1998, Microbiology and immunology,
A Kaneko, and H Miyazawa, and F Kirikae, and K Toyooka, and M Hashimoto, and S Yamasaki, and M Hasegawa, and C Takeuchi, and T Kuratsuji, and M Sumiya, and O Kobori, and Y Yazaki, and T Kirikae
October 2001, Journal of clinical microbiology,
A Kaneko, and H Miyazawa, and F Kirikae, and K Toyooka, and M Hashimoto, and S Yamasaki, and M Hasegawa, and C Takeuchi, and T Kuratsuji, and M Sumiya, and O Kobori, and Y Yazaki, and T Kirikae
October 1997, The Journal of veterinary medical science,
A Kaneko, and H Miyazawa, and F Kirikae, and K Toyooka, and M Hashimoto, and S Yamasaki, and M Hasegawa, and C Takeuchi, and T Kuratsuji, and M Sumiya, and O Kobori, and Y Yazaki, and T Kirikae
September 2002, The Medical journal of Malaysia,
Copied contents to your clipboard!